These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 19115229

  • 1. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A.
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [Abstract] [Full Text] [Related]

  • 2. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HW, Jaques AM.
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [Abstract] [Full Text] [Related]

  • 3. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK, Raatikainen K, Romppanen J, Pulkki K, Heinonen S.
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [Abstract] [Full Text] [Related]

  • 4. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection.
    Hui PW, Lam YH, Tang MH, NG EH, Yeung WS, Ho PC.
    Prenat Diagn; 2005 May; 25(5):390-3. PubMed ID: 15906430
    [Abstract] [Full Text] [Related]

  • 5. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [Abstract] [Full Text] [Related]

  • 6. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K, Bindra R, Cacho AM, Nicolaides KH.
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [Abstract] [Full Text] [Related]

  • 7. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction.
    Engels MA, Kooij M, Schats R, Twisk JW, Blankenstein MA, van Vugt JM.
    Prenat Diagn; 2010 Apr; 30(4):372-7. PubMed ID: 20225232
    [Abstract] [Full Text] [Related]

  • 8. In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies.
    Matilainen M, Peuhkurinen S, Laitinen P, Jarvela I, Morin-Papunen L, Ryynanen M.
    Fertil Steril; 2011 Jan; 95(1):378-81. PubMed ID: 20723891
    [Abstract] [Full Text] [Related]

  • 9. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
    Tul N, Novak-Antolic Z.
    Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
    [Abstract] [Full Text] [Related]

  • 10. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
    Bellver J, Lara C, Soares SR, Ramírez A, Pellicer A, Remohí J, Serra V.
    Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
    [Abstract] [Full Text] [Related]

  • 11. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C, Vanden Meerschaut F, De Roo C, Saunier O, Quarello E, Hairion D, Penaranda G, Chabert-Orsini V, De Sutter P.
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [Abstract] [Full Text] [Related]

  • 12. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length.
    Gjerris AC, Loft A, Pinborg A, Tabor A, Christiansen M.
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):612-7. PubMed ID: 18816495
    [Abstract] [Full Text] [Related]

  • 13. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J, Steinhard J, Schmitz R, Nofer JR, Witteler R, Mosel A, Ahrens A, Kiesel L, Klockenbusch W.
    Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
    [Abstract] [Full Text] [Related]

  • 14. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 15. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 16. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 17. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 18. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation.
    Anckaert E, Schiettecatte J, Sleurs E, Devroey P, Smitz J.
    Fertil Steril; 2008 Oct; 90(4):1206-10. PubMed ID: 18164000
    [Abstract] [Full Text] [Related]

  • 19. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [Abstract] [Full Text] [Related]

  • 20. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.